ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
Dow Jones
39.387,76
0,85%
Euro vs US Dollar
1,07765
-0,05%
Bitcoin
62.862,67
-0,29%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Axonics Inc (AXNX)

  7. Axonics Inc (AXNX) News

AXNX

Axonics (AXNX)

Axonics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AXNX
DatumZeitQuelleÜberschriftSymbolFirma
30/04/202422h01Business WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
24/04/202412h30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
22/03/202421h01Business WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
21/03/202421h54Business WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
14/03/202411h00Business WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
07/03/202423h24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
29/02/202422h01Business WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
28/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
28/02/202422h01Business WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
22/02/202414h00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
03/02/202400h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
02/02/202423h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
31/01/202412h30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
11/01/202402h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
10/01/202421h07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
08/01/202423h19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
08/01/202423h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
08/01/202422h55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202417h36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202414h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
08/01/202413h41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
08/01/202413h00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202413h00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202413h00Business WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
29/12/202301h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
27/12/202322h01Business WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
26/12/202319h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
06/11/202318h00GlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
 Showing the most relevant articles for your search:NASDAQ:AXNX

Kürzlich von Ihnen besucht

AMEX
XLF
Financial Select Sector
NASDAQ
MSFT
Microsoft
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
FX
EURJPY
Euro vs Yen
TG
MBG
MercedesBenz
TG
BAS
BASF
AMEX
SPY
SPDR S&P 500
CCOM
US100
US Tech 100
CCOM
US30
US 30
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten